Natera Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -98.83. In total, the insiders bought 36.11K and sold 237.86K NTRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-98.83 |
| ● Buy | 36.11K shares |
| ● Sell | 237.86K shares |
|
18% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jul 06, 2026 Sell |
Rabinowitz Matthew Executive Chairman |
1 000 Value: $280.0K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
1 400 Value: $386.7K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
1 100 Value: $302.7K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
500 Value: $137.1K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
1 932 Value: $519.7K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
3 705 Value: $993.3K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
1 568 Value: $418.3K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
484 Value: $130.6K |
||
|
Jul 01, 2026 Sell |
Moshkevich Solomon President, Clinicaldiagnostics |
2 600 Value: $709.8K |
||
|
Jul 01, 2026 Sell |
Moshkevich Solomon President, Clinicaldiagnostics |
100 Value: $26.7K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
1 357 Value: $367.7K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
2 045 Value: $567.1K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
1 955 Value: $544.0K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
300 Value: $83.6K |
||
|
Jul 01, 2026 Sell |
Rabinowitz Daniel Sec. And Chief Legal Officer |
454 Value: $123.6K |
||
|
Jul 01, 2026 Sell |
Moshkevich Solomon President, Clinicaldiagnostics |
300 Value: $82.2K |
||
|
Jun 26, 2026 Buy |
Bertagnolli Monica Director |
75 Value: $19.6K |
||
|
Jun 26, 2026 Buy |
Bertagnolli Monica Director |
1 571 Value: $411.5K |
||
|
Jun 26, 2026 Buy |
Baynes Roy D. Director |
75 Value: $19.6K |
||
|
Jun 26, 2026 Buy |
Baynes Roy D. Director |
1 571 Value: $411.5K |
||
|
Jun 26, 2026 Buy |
Rubin Eric H Director |
75 Value: $19.6K |
||
|
Jun 26, 2026 Buy |
Botha Roelof Director |
120 Value: $31.4K |
||
|
Jun 26, 2026 Buy |
Botha Roelof Director |
1 571 Value: $411.5K |
||
|
Jun 26, 2026 Buy |
Rosenman Herm Director |
106 Value: $27.8K |
||
|
Jun 26, 2026 Buy |
Rosenman Herm Director |
1 571 Value: $411.5K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
Sign In
Buy NTRA